Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A First Human Study of a Ferroportin Antibody

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: March 15, 2011
Last updated: September 26, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)